Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases
- 31 August 2000
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 26 (5), 468-473
- https://doi.org/10.1053/ejso.1999.0924
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.Journal of Clinical Oncology, 1998
- Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litreBritish Journal of Cancer, 1997
- Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastasesBritish Journal of Surgery, 1995
- Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasesThe Lancet, 1994
- A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin.A potential adjuvant program after resection of colorectal hepatic metastasesCancer, 1993
- Regional infusion chemotherapy for colorectal hepatic metastases—where is it going?Cancer Treatment Reviews, 1991
- Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistBritish Journal of Cancer, 1990
- Pyroxidine for the Palmar-Plantar Erythrodysesthesia SyndromeAnnals of Internal Medicine, 1989
- Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterialversus continuous intraarterial/intravenous therapy). Results of a controlled clinical trialCancer, 1989
- Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusionCancer, 1986